An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1

Overview of attention for article published in Frontiers in oncology, April 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer

Article in Cancers (September 2024)

A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis

Article in Annals of Hematology (August 2024)

Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia

Article in BJC Reports (July 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.